Statin-Induced Ca2+ Release was Increased in B Lymphocytes in Patients who Showed Elevated Serum Creatine Kinase During Statin Treatment
Open Access
- 1 January 2009
- journal article
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 16 (6) , 870-877
Abstract
Aim: Statins are effective in lowering cholesterol levels, but cause fatal rhabdomyolysis in susceptible individuals. Because it has been hypothesized that muscle damage could result from alterations in Ca2+ homeostasis in muscle cells, we tested whether measuring statin-induced changes in intracellular calcium ([Ca2+]i) is useful for predicting susceptibility to statin-muscle damage, using human CD19+ primary B lymphocytes. Methods: Statin-induced alterations in [Ca2+]i were studied using the human THP-1 cell line and CD19+ primary B lymphocytes. Changes in [Ca2+]i were measured directly in fluo-3- loaded cells using either single or dual-color flow cytometry. Results: The Ca2+ release study suggested that statin-induced changes in [Ca2+]i were due to Ca2+ release from ryanodine-sensitive Ca2+ stores and mitochondrial compartments. Further, statin users who experienced elevated creatine kinase (n=8) exhibited significantly greater statin-induced Ca2+ release in B cells than healthy volunteers (n=45) and statin users without elevated creatine kinase (n=16), while no difference was seen between the latter two groups. Conclusion: Statin-induced Ca2+ release from ryanodine-sensitive stores and mitochondria may contribute to myotoxicity. The laboratory test for Ca2+ release using CD19+ primary B lymphocytes may be useful to predict susceptibility to statin-induced muscle toxicity prior to statin use.Keywords
This publication has 43 references indexed in Scilit:
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide StudyNew England Journal of Medicine, 2008
- Atorvastatin induces apoptosis by a caspase-9-dependent pathway: an in vitro study on activated rat hepatic stellate cellsLiver International, 2008
- The mitochondrial ryanodine receptor in rat heart: A pharmaco-kinetic profileBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Fluvastatin and Atorvastatin Affect Calcium Homeostasis of Rat Skeletal Muscle Fibers in Vivo and in Vitro by Impairing the Sarcoplasmic Reticulum/Mitochondria Ca2+-Release SystemThe Journal of Pharmacology and Experimental Therapeutics, 2007
- The Safety of Rosuvastatin as Used in Common Clinical PracticeCirculation, 2005
- Malignant hyperthermia susceptibility revealed by increased serum creatine kinase concentrations during statin treatmentEuropean Journal of Anaesthesiology, 2004
- Atorvastatin Treatment Prevents Alterations in Coronary Smooth Muscle Nuclear Ca2+ Signaling in Diabetic DyslipidemiaJournal of Vascular Research, 2002
- Multiple effects of caffeine on Ca2+release and influx in human B lymphocytesCell Calcium, 2001
- Cytosolic Ca2+ Increase and Cell Damage in L6 Rat Myoblasts by HMG-CoA Reductase InhibitorsBiochemical and Biophysical Research Communications, 1994
- The Malignant Hyperthermia SyndromeNew England Journal of Medicine, 1983